Respiratory Disorders Drug and Forecast Market

List of Tables
Table 1. Respiratory Disorders Drug Market Opportunities & Trends in Global Market
Table 2. Respiratory Disorders Drug Market Drivers in Global Market
Table 3. Respiratory Disorders Drug Market Restraints in Global Market
Table 4. Key Players of Respiratory Disorders Drug in Global Market
Table 5. Top Respiratory Disorders Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Respiratory Disorders Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Respiratory Disorders Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies Respiratory Disorders Drug Product Type
Table 9. List of Global Tier 1 Respiratory Disorders Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Respiratory Disorders Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Respiratory Disorders Drug Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Respiratory Disorders Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Respiratory Disorders Drug Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Respiratory Disorders Drug Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Respiratory Disorders Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Respiratory Disorders Drug Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Respiratory Disorders Drug Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Respiratory Disorders Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Respiratory Disorders Drug Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Respiratory Disorders Drug Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Respiratory Disorders Drug Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Respiratory Disorders Drug Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Respiratory Disorders Drug Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Respiratory Disorders Drug Revenue, (US$, Mn), 2024-2030
Table 30. AstraZeneca Company Summary
Table 31. AstraZeneca Respiratory Disorders Drug Product Offerings
Table 32. AstraZeneca Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 33. AstraZeneca Key News & Latest Developments
Table 34. MSD Company Summary
Table 35. MSD Respiratory Disorders Drug Product Offerings
Table 36. MSD Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 37. MSD Key News & Latest Developments
Table 38. Boehringer Ingelheim Company Summary
Table 39. Boehringer Ingelheim Respiratory Disorders Drug Product Offerings
Table 40. Boehringer Ingelheim Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 41. Boehringer Ingelheim Key News & Latest Developments
Table 42. Biogen Company Summary
Table 43. Biogen Respiratory Disorders Drug Product Offerings
Table 44. Biogen Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 45. Biogen Key News & Latest Developments
Table 46. Pfizer Company Summary
Table 47. Pfizer Respiratory Disorders Drug Product Offerings
Table 48. Pfizer Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 49. Pfizer Key News & Latest Developments
Table 50. Teva Company Summary
Table 51. Teva Respiratory Disorders Drug Product Offerings
Table 52. Teva Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 53. Teva Key News & Latest Developments
Table 54. Novartis Company Summary
Table 55. Novartis Respiratory Disorders Drug Product Offerings
Table 56. Novartis Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 57. Novartis Key News & Latest Developments
Table 58. Johnson & Johnson Company Summary
Table 59. Johnson & Johnson Respiratory Disorders Drug Product Offerings
Table 60. Johnson & Johnson Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 61. Johnson & Johnson Key News & Latest Developments
Table 62. Eli Lilly Company Summary
Table 63. Eli Lilly Respiratory Disorders Drug Product Offerings
Table 64. Eli Lilly Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 65. Eli Lilly Key News & Latest Developments
Table 66. Otsuka Company Summary
Table 67. Otsuka Respiratory Disorders Drug Product Offerings
Table 68. Otsuka Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 69. Otsuka Key News & Latest Developments
Table 70. Merck Company Summary
Table 71. Merck Respiratory Disorders Drug Product Offerings
Table 72. Merck Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 73. Merck Key News & Latest Developments
Table 74. Takeda Company Summary
Table 75. Takeda Respiratory Disorders Drug Product Offerings
Table 76. Takeda Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 77. Takeda Key News & Latest Developments
Table 78. FibroGen Company Summary
Table 79. FibroGen Respiratory Disorders Drug Product Offerings
Table 80. FibroGen Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 81. FibroGen Key News & Latest Developments
Table 82. Amgen Company Summary
Table 83. Amgen Respiratory Disorders Drug Product Offerings
Table 84. Amgen Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 85. Amgen Key News & Latest Developments
Table 86. Dr. Reddy's Laboratories Company Summary
Table 87. Dr. Reddy's Laboratories Respiratory Disorders Drug Product Offerings
Table 88. Dr. Reddy's Laboratories Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 89. Dr. Reddy's Laboratories Key News & Latest Developments
Table 90. Dainippon Sumitomo Company Summary
Table 91. Dainippon Sumitomo Respiratory Disorders Drug Product Offerings
Table 92. Dainippon Sumitomo Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 93. Dainippon Sumitomo Key News & Latest Developments
Table 94. Abbott Company Summary
Table 95. Abbott Respiratory Disorders Drug Product Offerings
Table 96. Abbott Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 97. Abbott Key News & Latest Developments
Table 98. Horizon Pharma Company Summary
Table 99. Horizon Pharma Respiratory Disorders Drug Product Offerings
Table 100. Horizon Pharma Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 101. Horizon Pharma Key News & Latest Developments
Table 102. Zambon Company Summary
Table 103. Zambon Respiratory Disorders Drug Product Offerings
Table 104. Zambon Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 105. Zambon Key News & Latest Developments
Table 106. Moehs Company Summary
Table 107. Moehs Respiratory Disorders Drug Product Offerings
Table 108. Moehs Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 109. Moehs Key News & Latest Developments
Table 110. Pharmazell Company Summary
Table 111. Pharmazell Respiratory Disorders Drug Product Offerings
Table 112. Pharmazell Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 113. Pharmazell Key News & Latest Developments
Table 114. Nippon Rika Company Summary
Table 115. Nippon Rika Respiratory Disorders Drug Product Offerings
Table 116. Nippon Rika Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 117. Nippon Rika Key News & Latest Developments
Table 118. Chengyi Pharma Company Summary
Table 119. Chengyi Pharma Respiratory Disorders Drug Product Offerings
Table 120. Chengyi Pharma Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 121. Chengyi Pharma Key News & Latest Developments
Table 122. Wuhan Grand Hoyo Company Summary
Table 123. Wuhan Grand Hoyo Respiratory Disorders Drug Product Offerings
Table 124. Wuhan Grand Hoyo Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 125. Wuhan Grand Hoyo Key News & Latest Developments
Table 126. Manus Aktteva Biopharma Company Summary
Table 127. Manus Aktteva Biopharma Respiratory Disorders Drug Product Offerings
Table 128. Manus Aktteva Biopharma Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 129. Manus Aktteva Biopharma Key News & Latest Developments
Table 130. Beijing Jiuhe Pharmaceutical Company Summary
Table 131. Beijing Jiuhe Pharmaceutical Respiratory Disorders Drug Product Offerings
Table 132. Beijing Jiuhe Pharmaceutical Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 133. Beijing Jiuhe Pharmaceutical Key News & Latest Developments
Table 134. Daiichi Sankyo Pharmaceutical Company Summary
Table 135. Daiichi Sankyo Pharmaceutical Respiratory Disorders Drug Product Offerings
Table 136. Daiichi Sankyo Pharmaceutical Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 137. Daiichi Sankyo Pharmaceutical Key News & Latest Developments
Table 138. Sinopharm Company Summary
Table 139. Sinopharm Respiratory Disorders Drug Product Offerings
Table 140. Sinopharm Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 141. Sinopharm Key News & Latest Developments
Table 142. CTTQ Company Summary
Table 143. CTTQ Respiratory Disorders Drug Product Offerings
Table 144. CTTQ Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 145. CTTQ Key News & Latest Developments
Table 146. Yangtze River Pharmaceutical Group Company Summary
Table 147. Yangtze River Pharmaceutical Group Respiratory Disorders Drug Product Offerings
Table 148. Yangtze River Pharmaceutical Group Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 149. Yangtze River Pharmaceutical Group Key News & Latest Developments
List of Figures
Figure 1. Respiratory Disorders Drug Segment by Type in 2022
Figure 2. Respiratory Disorders Drug Segment by Application in 2022
Figure 3. Global Respiratory Disorders Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Respiratory Disorders Drug Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Respiratory Disorders Drug Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Respiratory Disorders Drug Revenue in 2022
Figure 8. By Type - Global Respiratory Disorders Drug Revenue Market Share, 2018-2030
Figure 9. By Application - Global Respiratory Disorders Drug Revenue Market Share, 2018-2030
Figure 10. By Type - Global Respiratory Disorders Drug Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Respiratory Disorders Drug Revenue Market Share, 2018-2030
Figure 12. By Application - Global Respiratory Disorders Drug Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Respiratory Disorders Drug Revenue Market Share, 2018-2030
Figure 14. By Region - Global Respiratory Disorders Drug Revenue Market Share, 2018-2030
Figure 15. By Country - North America Respiratory Disorders Drug Revenue Market Share, 2018-2030
Figure 16. US Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Respiratory Disorders Drug Revenue Market Share, 2018-2030
Figure 20. Germany Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 21. France Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Respiratory Disorders Drug Revenue Market Share, 2018-2030
Figure 28. China Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 32. India Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Respiratory Disorders Drug Revenue Market Share, 2018-2030
Figure 34. Brazil Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Respiratory Disorders Drug Revenue Market Share, 2018-2030
Figure 37. Turkey Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 41. AstraZeneca Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. MSD Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Boehringer Ingelheim Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Biogen Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Pfizer Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Teva Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Novartis Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Johnson & Johnson Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Eli Lilly Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Otsuka Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Merck Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Takeda Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. FibroGen Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Amgen Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Dr. Reddy's Laboratories Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Dainippon Sumitomo Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Abbott Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Horizon Pharma Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Zambon Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. Moehs Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 61. Pharmazell Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 62. Nippon Rika Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 63. Chengyi Pharma Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 64. Wuhan Grand Hoyo Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 65. Manus Aktteva Biopharma Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 66. Beijing Jiuhe Pharmaceutical Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 67. Daiichi Sankyo Pharmaceutical Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 68. Sinopharm Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 69. CTTQ Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 70. Yangtze River Pharmaceutical Group Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)